Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-29
2006-08-29
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S343000, C544S338000, C546S192000
Reexamination Certificate
active
07098215
ABSTRACT:
The present invention provides novel compounds having antiviral activities and antiviral drugs containing the compounds as the active ingredient. The compounds are shown by the following general formula (1),wherein typically A1and A2are each guanidine or a group of the general formula (ia); A3is a mono- or poly-cyclic heteroaromatic ring containing 1 or 2 heteroatoms; B1is a single bond or alkylene group; R1is hydrogen or alkyl group; W is an alkylene having 2-3 carbons, a cycloalkylene having 5-10 carbons, aromatic ring having 6-10 carbons, or a heteroaromatic ring having 5-10 carbons; y is C(═O)—; x is —C(═O)—NH—; n1is an integer of 1-2; n2is an integer of 2-3; D is a substituent selected from among various groups
REFERENCES:
patent: 5086069 (1992-02-01), Klein et al.
patent: 5633231 (1997-05-01), Habich et al.
patent: 5886044 (1999-03-01), Widdowson et al.
patent: 6096773 (2000-08-01), Scott et al.
patent: 2004/0157818 (2004-08-01), Yanaka et al.
patent: 2004/0254221 (2004-12-01), Yamazaki et al.
patent: 183271 (1986-06-01), None
patent: 628551 (1994-12-01), None
patent: 0 646 598 (1995-04-01), None
patent: 1 389 460 (2004-02-01), None
patent: 7-89988 (1995-04-01), None
patent: WO 98/06397 (1998-02-01), None
patent: WO 99/33787 (1999-07-01), None
patent: WO 01/10842 (2001-02-01), None
patent: WO 02/094261 (2002-05-01), None
U.S. Appl. No. 10/516,158, filed Nov. 30, 2004, Yamazaki et al.
Molino, M., et al., “CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2,” Biochimica et Biophysica Acta (BBA), Molecular Basis of Disease, vol. 1500, Issue 2, Feb. 21, 2000, p. 227-240.
Hirose Kunitaka
Maruoka Hiroshi
Mukade Tsutomu
Suzuki Shigeru
Yamamoto Naoki
Hollander Law Firm, P.L.C.
Kureha Chemical Industry Co. Ltd.
Saeed Kamal A.
LandOfFree
Nitrogenous compounds and antiviral drugs containing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrogenous compounds and antiviral drugs containing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogenous compounds and antiviral drugs containing the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3616504